Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Cash flows from operating activities    
Net loss $ (4,316) $ (1,147)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Realized (gain) loss on marketable debt securities 40 (2)
Depreciation and amortization 2,044 253
Amortization of debt discount 4
Amortization on right-of-use assets 247
Lower of cost or net realizable value inventory adjustment 17
Stock-based compensation expense 2,438 679
Change in fair value of investment securities 101
Non-cash interest income on secured promissory note receivable (315)
Changes in operating assets and liabilities:    
Accounts receivable (7,327) (1,015)
Escrow receivable 4,812
Inventory (5,036) (696)
Prepaid and other assets 1,639 (30)
Other assets (368)
Accounts payable and accrued expenses (1,749) 470
Accrued diagnostic services 3,260
Deferred revenue 1,461  
Lease liabilities 197
Other liabilities (1,292) 835
Net cash (used in) provided by operating activities (8,972) 4,176
Cash flows from investing activities    
Business acquisitions, net of cash acquired (9,066)
Issuance of secured promissory note receivable (1,000) (2,974)
Purchase of marketable securities (21,527) (4,317)
Proceeds from sale of marketable debt securities 10,701 3,839
Capital expenditures (4,258) (222)
Net cash used in investing activities (25,150) (3,674)
Cash flows from financing activities    
Proceeds from issuance of common stock from public offering, net 35,135
Proceeds from issuance of common stock and warrants from private offering 5,500
Proceeds from unsecured convertible promissory notes 10,000
Issuance costs on unsecured convertible promissory notes (10)
Payment of issuance costs in connection with ATM (66)
Payment of dividends (4,546)
Net cash provided by financing activities 36,089 9,924
Increase in cash, cash equivalents and restricted cash 1,967 10,426
Cash, cash equivalents and restricted cash, at the beginning of the period 6,816 434
Cash, cash equivalents and restricted cash, at the end of the period 8,783 10,860
Supplemental disclosures:    
Cash paid for income taxes
Interest payment on the promissory notes 750
Supplemental disclosure of non-cash investing and financing activities:    
Issuance of common shares related to business acqusition 3,608
Net unrealized loss, investments in marketable debt securities $ (111) $ (2)